Independence Bank of Kentucky’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.5M | Sell |
62,267
-2,135
| -3% | -$55.8K | 0.17% | 113 |
|
|
2026
Q1 | $1.81M | Sell |
64,402
-3,763
| -6% | -$100K | 0.23% | 89 |
|
|
2025
Q4 | $1.7M | Sell |
68,165
-878
| -1% | -$22.1K | 0.21% | 96 |
|
|
2025
Q3 | $1.76M | Sell |
69,043
-1,891
| -3% | -$46.7K | 0.23% | 89 |
|
|
2025
Q2 | $1.72M | Buy |
70,934
+1,626
| +2% | +$37.9K | 0.24% | 90 |
|
|
2025
Q1 | $1.76M | Sell |
69,308
-4,605
| -6% | -$121K | 0.27% | 82 |
|
|
2024
Q4 | $1.96M | Buy |
73,913
+3,457
| +5% | +$93.8K | 0.3% | 74 |
|
|
2024
Q3 | $2.04M | Buy |
70,456
+10,482
| +17% | +$306K | 0.44% | 53 |
|
|
2024
Q2 | $1.68M | Buy |
59,974
+316
| +0.5% | +$8.7K | 0.44% | 55 |
|
|
2024
Q1 | $1.66M | Sell |
59,658
-9,020
| -13% | -$250K | 0.5% | 48 |
|
|
2023
Q4 | $1.98M | Sell |
68,678
-5,940
| -8% | -$180K | 0.69% | 33 |
|
|
2023
Q3 | $2.48M | Sell |
74,618
-765
| -1% | -$27.1K | 1.05% | 21 |
|
|
2023
Q2 | $2.77M | Buy |
75,383
+315
| +0.4% | +$12.3K | 1.12% | 20 |
|
|
2023
Q1 | $3.06M | Buy |
75,068
+4,820
| +7% | +$208K | 1.33% | 15 |
|
|
2022
Q4 | $3.6M | Sell |
70,248
-2,610
| -4% | -$125K | 1.62% | 11 |
|
|
2022
Q3 | $3.19M | Sell |
72,858
-196
| -0.3% | -$9.52K | 1.57% | 12 |
|
|
2022
Q2 | $3.83M | Buy |
73,054
+236
| +0.3% | +$12K | 1.71% | 8 |
|
|
2022
Q1 | $3.77M | Buy |
72,818
+2,931
| +4% | +$152K | 1.49% | 14 |
|
|
2021
Q4 | $4.13M | Sell |
69,887
-3,675
| -5% | -$182K | 1.69% | 11 |
|
|
2021
Q3 | $3.16M | Sell |
73,562
-2,627
| -3% | -$116K | 1.37% | 18 |
|
|
2021
Q2 | $2.98M | Sell |
76,189
-345
| -0.5% | -$13.4K | 1.32% | 18 |
|
|
2021
Q1 | $2.77M | Buy |
76,534
+2,140
| +3% | +$76K | 1.35% | 20 |
|
|
2020
Q4 | $2.74M | Sell |
74,394
-7,469
| -9% | -$274K | 1.42% | 16 |
|
|
2020
Q3 | $2.85M | Buy |
81,863
+162
| +0.2% | +$5.68K | 1.62% | 12 |
|
|
2020
Q2 | $2.54M | Buy |
81,701
+3,888
| +5% | +$132K | 1.64% | 12 |
|
|
2020
Q1 | $2.41M | Buy |
77,813
+6,770
| +10% | +$231K | 1.89% | 9 |
|
|
2019
Q4 | $2.64M | Buy |
71,043
+2,121
| +3% | +$75.5K | 1.71% | 11 |
|
|
2019
Q3 | $2.35M | Buy |
68,922
+7,955
| +13% | +$289K | 1.67% | 11 |
|
|
2019
Q2 | $2.51M | Sell |
60,967
-110
| -0.2% | -$4.37K | 1.96% | 11 |
|
|
2019
Q1 | $2.46M | Sell |
61,077
-116
| -0.2% | -$4.65K | 2.01% | 11 |
|
|
2018
Q4 | $2.53M | Sell |
61,193
-4,954
| -7% | -$206K | 2.3% | 8 |
|
|
2018
Q3 | $2.77M | Sell |
66,147
-5,032
| -7% | -$194K | 2.17% | 8 |
|
|
2018
Q2 | $2.45M | Buy |
71,179
+224
| +0.3% | +$7.66K | 2.05% | 11 |
|
|
2018
Q1 | $2.39M | Buy |
70,955
+546
| +0.8% | +$18.8K | 2.03% | 10 |
|
|
2017
Q4 | $2.42M | Buy |
+70,409
| New | +$2.4M | 2.07% | 12 |
|
Other funds holding PFE
AIM
SLAM
CWP
Independence Bank of Kentucky's PFE Position: Q2 2026 in Review
Independence Bank of Kentucky reduced its Pfizer (PFE) stake by 3.3% in Q2 2026, selling an estimated $55.8K and leaving 62,267 shares worth $1.5M. The position accounts for 0.17% of the portfolio, ranked #113.
Independence Bank of Kentucky first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.13M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Independence Bank of Kentucky held 62,267 shares of Pfizer worth $1.5M as of Q2 2026.
- Independence Bank of Kentucky sold 2,135 Pfizer shares in Q2 2026, an estimated $55.8K.
- Pfizer made up 0.17% of Independence Bank of Kentucky's portfolio in Q2 2026, its #113 holding.
- Independence Bank of Kentucky first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Independence Bank of Kentucky's Pfizer position peaked at $4.13M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.